Showing results (161-170 of 224) with videos related to

Sort By:
Pageof 23
Journal of Clinical Pharmacology|February 27, 2016
The Use of Dried Blood Spots for Pharmacokinetic Monitoring of Vemurafenib Treatment in Melanoma PatientsCynthia M Nijenhuis, Alwin D R Huitema, Serena Marchetti, et al.
Clinical Pharmacology and Therapeutics|July 21, 2020
Exposure-Response Analyses of Anaplastic Lymphoma Kinase Inhibitors Crizotinib and Alectinib in Non-Small Cell Lung Cancer PatientsStefanie L Groenland, Dieuwertje R Geel, Julie M Janssen, et al.
CPT: Pharmacometrics & Systems Pharmacology|October 26, 2019
Pharmacokinetics of Capecitabine and Four Metabolites in a Heterogeneous Population of Cancer Patients: A Comprehensive AnalysisBart A W Jacobs, Maarten J Deenen, Markus Joerger, et al.
American Journal of Physiology. Cell Physiology|February 23, 2007
Breast cancer resistance protein (Bcrp1/Abcg2) is expressed in the harderian gland and mediates transport of conjugated protoporphyrin IXJohan W Jonker, Sandra Musters, Maria L H Vlaming, et al.
Investigational New Drugs|November 8, 2014
Pharmacokinetics and excretion of (14)C-lenvatinib in patients with advanced solid tumors or lymphomasAnne-Charlotte Dubbelman, Hilde Rosing, Cynthia Nijenhuis, et al.
Clinical Pharmacology and Therapeutics|November 20, 2025
Reducing the Burden of Interaction Studies in Cancer Patients Using a Stable Isotopically Labeled Microtracer: A Proof-of-Concept Study with AlectinibMa Ida Mohmaed Ali, Lisa T van der Heijden, Matthijs Tibben, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|January 12, 2021
Cost-Effectiveness Assessment of Monitoring Abiraterone Levels in Metastatic Castration-Resistant Prostate Cancer PatientsRenske M T Ten Ham, Merel van Nuland, Rick A Vreman, et al.
Pageof 23